Home Site Map Search Members Only Contact Us
Addiction Treatment

Vancouver is recognized internationally for its innovative and comprehensive strategy to address drug addiction and its associated harms. UHRI has conducted a wealth of research in this setting to determine the most effective modes of treatment for drug addiction and to identify the policies, programs and interventions that limit access to, or facilitate uptake of, drug addiction treatment.

Publications

  • Young SV, Wood E, Ahamad K. Pharmacotherapy for alcohol addiction in a patient with alcoholic cirrhosis and massive upper gastrointestinal bleed: A case study.Drug and Alcohol Review, 2015 Jun 18 [Epub ahead of print]. PubMed
  • Voon P, Hayashi K, Milloy MJ, Nguyen P, Wood E, Montaner J, Kerr T. Pain among high-risk patients on methadone maintenance treatment. Journal of Pain, 2015 Jun 20 [Epub ahead of print]. PubMed
  • Milloy MJ, Wood E. Withdrawal from methadone in US prisons: Cruel and unusual? Lancet, 2015 May 28 [Epub ahead of print]. PubMed
  • Lyons T, Shannon K, Richardson L, Simo A, Wood E, Kerr T. Women who use drugs and have sex with women in a Canadian setting: Barriers to treatment enrollment and exposure to violence and homelessness. Archives of Sexual Behavior, 2015 May 27 [Epub ahead of print]. PubMed
  • McNeil R, Kerr T, Anderson S, Maher L, Keewatin C, Milloy MJ, Wood E, Small W. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study. Social Science & Medicine, 2015; 133(1): 168-176. PubMed
  • Uhlmann S, Milloy MJ, Ahamad K, Nguyen P, Kerr T, Wood E, Richardson L. Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs. American Journal on Addictions, 2015; 24(4): 368-373. PubMed
  • Lyons T, Shannon K, Pierre L, Small W, Krüsi A, Kerr T. A qualitative study of transgender individuals’ experiences in residential addiction treatment settings: Stigma and inclusivity. Substance Abuse Treatment, Prevention, and Policy, 2015; 10(1): 17. PubMed
  • Hayashi K, Ti L, Avihingsanon A, Kaplan K, Suwannawong P, Wood E, Montaner JS, Kerr T. Compulsory drug detention exposure is associated with not receiving antiretroviral treatment among people who inject drugs in Bangkok, Thailand: A cross-sectional study. Substance Abuse Treatment, Prevention, and Policy, 2015; 10(1): 16. PubMed
  • Ahamad K, Milloy MJ, Nguyen P, Uhlmann S, Johnson C, Korthuis TP, Kerr T, Wood E. Factors associated with willingness to take extended release naltrexone among injection drug users. Addiction Science & Clinical Practice, 2015; 10(1): 12. PubMed
  • Lappalainen L, Nolan S, Dobrer S, Puskas C, Montaner J, Ahamad K, Dong H, Kerr T, Wood E, Milloy MJ. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive persons who use illicit opioids. Addiction, 2015 May 1 [Epub ahead of print]. PubMed
  • Bach P, Milloy MJ, Nguyen P, Koehn J, Guillemi S, Kerr T, Wood E. Gender differences in access to methadone maintenance therapy in a Canadian setting. Drug and Alcohol Review, 2015 Mar 4 [Epub ahead of print]. PubMed
  • Fairbairn N, Hayashi K, Ti L, Kaplan K, Suwannawong P, Wood E, Kerr T. Compulsory drug detention and injection drug use cessation and relapse in Bangkok, Thailand. Drug and Alcohol Review, 2015; 34(1): 74-81. PubMed
  • Krebs E, Kerr T, Montaner J, Wood E, Nosyk B. Dynamics in the costs of criminality among opioid dependent individuals. Drug and Alcohol Dependence, 2014; 144(1): 193-200. PubMed
  • Hayashi K, Ti L, Kaplan K, Suwannawong P, Wood E, Kerr T. Police interference with methadone treatment in Bangkok, Thailand. International Journal of Drug Policy, 2014; 26(1): 112-115. PubMed
  • Nolan S, Dias Lima V, Fairbairn N, Kerr T, Montaner J, Grebely J, Wood E. The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. Addiction, 2014; 109(12): 2053-2059. PubMed
  • Phillips M, DeBeck K, Desjarlais T, Morrison T, Feng C, Kerr T, Wood E. Inability to access addiction treatment among street-involved youth in a Canadian setting. Substance Use and Misuse, 2014; 49(10): 1233-1240. PubMed
  • Wood E, Samet JH, Volkow ND. Physician education in addiction medicine. Journal of the American Medical Association, 2013; 310(16): 1673-1674. PubMed
  • Reddon H, Milloy MJ, Simo A, Montaner J, Wood E, Kerr T. Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS and Behavior, 2014; 18(4): 740-746. PubMed
  • Kerr T, Hayashi K, Ti L, Kaplan K, Suwannawong P, Wood E. The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand. International Journal of Drug Policy, 2014; 25(1): 171-174. PubMed
  • Richardson L, Wood E, Montaner J, Kerr T. Addiction treatment-related employment barriers: The impact of methadone maintenance. Journal of Substance Abuse Treatment, 2012; 43(3): 276-284. PubMed Summary
  • Fairbairn N, Hayashi K, Kaplan K, Suwannawong P, Qi J, Wood E, Kerr T. Factors associated with methadone treatment among injection drug users in Bangkok, Thailand. Journal of Substance Abuse Treatment, 2012; 43(1): 108-113. PubMed
  • Debeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, Montaner J, Wood E. Injection drug use cessation and use of North America’s first medically supervised safer injecting facility. Drug and Alcohol Dependence, 2011; 113(2-3): 172-176. PubMed Summary
  • Milloy M-JS, Kerr T, Zhang R, Tyndall M, Montaner J, Wood E. Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility. Journal of Public Health, 2010; 32(3): 342-349. PubMed Summary
  • Palepu A, Marshall BDL, Lai C, Wood E, Kerr T. Addiction treatment and stable housing among a cohort of injection drug users. PLoS ONE, 2010; 5(7): e11697. PubMed
  • Pettes T, Wood E, Guillemi S, Lai C, Montaner J, Kerr T. Methadone use among HIV-positive injection drug users in a Canadian setting. Journal of Substance Abuse Treatment, 2010; 39(2): 174-179. PubMed
  • Uhlmann S, Milloy M-J, Kerr T, Zhang R, Guillemi S, Marsh D, Hogg RS, Montaner JSG, Wood E. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction, 2010; 105(5): 907-913. PubMed
  • Wong J, Marshall BDL, Kerr T, Lai C, Wood E. Addiction treatment experience among a cohort of street-involved youths and young adults. Journal of Child & Adolescent Substance Abuse, 2009; 18(4): 398-409.
  • Hadland SE, Kerr T, Li K, Montaner JS, Wood E. Access to drug and alcohol treatment among a cohort of street-involved youth. Drug and Alcohol Dependence, 2009; 101(1-2): 1-7. PubMed Summary
  • Werb D, Kerr T, Marsh D, Li K, Montaner JS. Wood E. Effect of methadone treatment on incarceration rates among injection drug users. European Addiction Research. 2008; 14(3): 143-149. PubMed
  • Wood E, Montaner JS, Li K, Barney L, Tyndall MW, Kerr T. Rate of methadone use among Aboriginal opioid injection drug users. Canadian Medical Association Journal. 2007; 177(1): 37-40. PubMed
  • Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction, 2007; 102(6): 916-919. PubMed
  • Werb D, Elliott R, Fischer B, Wood E, Montaner J, Kerr T. Drug treatment courts in Canada: An evidence-based review. HIV/AIDS Policy & Law Review, 2007; 12(2-3): 12-17. PubMed
  • Callon C, Wood E, Marsh D, Li K, Montaner J, Kerr T. Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver. Journal of Opioid Management, 2006; 2(1): 35-41. PubMed
  • Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug and Alcohol Dependence, 2006; 84(2): 188-194. PubMed
  • Wood E, Lim R, Kerr T. Initiation of opiate addiction in a Canadian prison: A case report. Harm Reduction Journal, 2006; 3(1): 11. PubMed
  • Maas B, Kerr T, Fairbairn N, Montaner J, Wood E. Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence. Expert Opinion on Drug Metabolism & Toxicology, 2006; 2(4): 533-543. PubMed
  • Wood E, Tyndall MW, Zhang R, Stoltz JA, Lai C, Montaner JS, Kerr T. Attendance at supervised injecting facilities and use of detoxification services. New England Journal of Medicine, 2006; 354(23): 2512-2514. PubMed
  • Wood E, Li K, Palepu A, Marsh DC , Schechter MT, Hogg RS, Montaner JS, Kerr T. Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users. Substance Use & Misuse, 2005; 40(8): 1153-1167. PubMed
  • Miller CL, Strathdee SA, Kerr T, Small W, Li K, Wood E. Factors associated with willingness to participate in a heroin prescription program among injection drug users. Journal of Opioid Management, 2005; 1(4): 201-203. PubMed
  • Wood E, Hogg RS, Kerr T, Palepu A, Zhang R, Montaner JS. Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naïve HIV-infected injection drug users. AIDS, 2005; 19(8): 837-839. PubMed
  • Kerr T, Marsh D, Li K, Montaner JS, Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug and Alcohol Dependence, 2005; 80(3): 329-335. PubMed
  • Wood E, Spittal P, Li K, Kerr T, Miller CL, Hogg RS, Montaner JS, Schechter MT. Inability to access addiction treatment and risk of HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes, 2004; 36(2): 750-754. PubMed
  • Kerr T, Wodak A, Elliott R, Montaner JS, Wood E. Opioid substitution and HIV/AIDS treatment and prevention. Lancet, 2004; 364(9449): 1918-1919. PubMed